Carlos Guanche, MD
Sports Medicine · Tarzana, CANPI 1518997154
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.3%), ownership interests and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Arthrex at 49.2% of the total. Reporting peaked in 2019 at $55,181 and has fallen 99.9% since, to $67 in 2025. Among sports medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $1100.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$55K
- Anika Therapeutics, Inc.$35K
- Linvatec Corporation$20K
- Medacta USA, Inc.$502
- Innovation Technologies Inc$385
- Smith+Nephew$235
- plus $353 from 5 others
What the payments were for
- Royalty or licence$2,8633%
- Consulting fees$17,70016%
- Speaking & faculty fees$47,45042%
- Travel & lodging$6,0085%
- Food & beverage$2,8163%
- Ownership interest$28,84326%
- Other$6,6186%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 15 | $55,263 |
| Anika Therapeutics, Inc. | 4 | $35,461 |
| Linvatec Corporation | 61 | $20,098 |
| Medacta USA, Inc. | 4 | $502 |
| Innovation Technologies Inc | 5 | $385 |
| Smith+Nephew | 6 | $235 |
| Saxum Surgical, Inc. | 1 | $165 |
| Johnson & Johnson | 3 | $137 |
| Orthofix Medical, Inc. | 1 | $19 |
| Boston Scientific | 1 | $17 |
| Stryker | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINVATEC HIP PRESERVATION SYSTEM$13,949
- BioBrace 23mm$4,490
- KNEE & HIP INSTRUMENTS HIP DISPOSABLE$2,863
- KNEE & HIP IMPLANTS HIP PUSHLOCKS$2,863
- KNEE & HIP INSTRUMENTS HIP REUSABLE$2,863
- LINVATEC SHOULDER ARTHROSCOPY$1,368
- LINVATEC ARTHROSCOPY$933
- KNEE & HIP INSTRUMENTS HIP INSTRUMENTS$468
- REVERSE SHOULDER$245
- Irrisept$220
- NEXT AR$133
- PRIMARY SHOULDER$125
How this compares
$112,297 in reported general payments places this provider in the 90th percentile of 662 sports medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 82 | $428 |
| Doxycycline Hyclate | 52 | $233 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Tarzana
- Neal ElattracheLos Angeles$51M
- Nathaniel CohenLos Gatos$6.4M
- Thomas KnappSanta Monica$2.5M
- Michael FreehillStanford$1.6M
- Allan MishraMenlo Park$1.5M
- Heinz Hoeneckela Jolla$1.4M
- Seth ShermanStanford$1.1M
- Stephan YacoubianBurbank$1M
- Stephen Snydervan Nuys$922K
- Deryk JonesSan Carlos$915K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.